mizoribine has been researched along with Connective Tissue Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S | 1 |
| Kishimoto, M; Nomura, A; Ohara, Y; Ohde, S; Okada, M; Rokutanda, R; Shimizu, H; Suyama, Y; Yamaguchi, K | 1 |
1 review(s) available for mizoribine and Connective Tissue Diseases
| Article | Year |
|---|---|
[Renal involvement in connective tissue diseases].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Connective Tissue Diseases; Humans; Immunosuppressive Agents; Kidney Diseases; Methylprednisolone; Pulse Therapy, Drug; Ribonucleosides; Tacrolimus | 2009 |
1 other study(ies) available for mizoribine and Connective Tissue Diseases
| Article | Year |
|---|---|
Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Connective Tissue Diseases; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Retrospective Studies; Ribonucleosides; Time Factors; Treatment Outcome | 2014 |